NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

OBGYN & Reproduction Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Menopause



Data on menopause described by researchers at University of Medicine and Dentistry of New Jersey



October 26th, 2009

"The aim of this study was to investigate the effectiveness of microdose transdermal 17 beta-estradiol (E-2) therapy in postmenopausal women with moderate to severe vulvovaginal symptoms. This report is based on a subset of 121 women who reported most bothersome moderate or severe vulvovaginal symptoms at baseline, from a previous randomized, double-blind, placebo-controlled, multicenter study of 425 healthy, symptomatic, postmenopausal women," scientists in the United States report.

"Recruits had experienced at least 7 moderate or severe hot flushes daily for at least I week or at least 50 moderate or severe hot flushes per week for at least 1 week. Effects on...


Source: OBGYN & Reproduction Week (2009-10-26)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login